Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of 2026-04-13, ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at $12.95, posting a 2.78% gain in the current session. This analysis covers key market context, technical support and resistance levels, and potential near-term scenarios for the clinical-stage biotech stock, with a focus on key levels market participants are monitoring in the current environment. No recent earnings data is available for PMN as of this date, so recent price action is primarily being driven by techni
What events could move ProMIS (PMN) Stock next | Price at $12.95, Up 2.78% - Take Profit Levels
PMN - Stock Analysis
4999 Comments
1564 Likes
1
Ambor
Active Contributor
2 hours ago
Clear and concise analysis — appreciated!
👍 194
Reply
2
Ambriah
Regular Reader
5 hours ago
I read this like it was a prophecy.
👍 183
Reply
3
Heberto
Legendary User
1 day ago
I read this and now I trust nothing.
👍 234
Reply
4
Katurah
New Visitor
1 day ago
Ah, if only I had seen this sooner. 😞
👍 277
Reply
5
Maniah
New Visitor
2 days ago
Bringing excellence to every aspect.
👍 124
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.